DSH appoints Chief Strategy Officer for Japan
NEW YORK, JAPAN — 6 June, 2016 — Dentsu Sudler & Hennessey (DSH), a leading Japanese healthcare advertising agency, is pleased to announce that Jon Hussey has recently joined as chief strategy officer.
Hussey has more than 15 years marketing communications healthcare experience, most recently as president and managing director of Grey Healthcare Japan, where he led the organization through a profitable restructuring. He has also held positions at Pfizer in global marketing, and at Palio Communications as SVP client services. He served as Director of client services at McCann Health in Japan, leading the organization through an acquisition and restructuring.
Hussey’s therapeutic experience is broad and all encompassing, including immunology, cardiology, neurology, oncology, respiratory, and urology, with a focus on new product launches, orphan drugs and biologics.
“Jon is a great asset to the region, and with his understanding and experience in the Japan market, has immediately had a positive impact. Clients are looking for a deeper level of strategic support in this market and across the region and Jon’s engagement, insight and local knowledge give a unique advantage to our clients” said Max Jackson, CEO EMEA & APAC, Sudler.
Hussey has a Bachelor’s Degree in Economics from Northwestern University and an MBA in International Business/Marketing from the University of Chicago. He also completed an intensive Japanese language course at Nagoya Gakuin University.
For more information about Sudler, please contact: Max Jackson ([email protected])
About S&H Group
The S&H Group is a global healthcare marketing and communications organization with divisions in medical education, promotion, sales training, KOL engagement, digital solutions, and patient and consumer education. For more information, please visit www.sudler.com.
S&H is part of Young and Rubicam Group, and part of WPP (NASDAQ: WPPGY; www.wpp.com)